Skip to content

IMNM

Immunome, Inc.

Stock

$20.90+0.01 (+0.05%)Close Oct 2, 2026

Free cash flow, 2025
−$201M

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025−$201M—
2024−$118M—
2023−$8.4M—
2022−$29M—
2021−$18M—
2020−$13M—
2019−$9.8M—